BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,230,770 | +0.6% | 3,846,154 | 0.0% | 26.28% | -5.5% |
| Q2 2023 | $27,076,924 | -15.6% | 3,846,154 | 0.0% | 27.82% | -37.4% |
| Q1 2023 | $32,076,924 | -27.4% | 3,846,154 | 0.0% | 44.43% | -14.5% |
| Q4 2022 | $44,153,847 | -8.9% | 3,846,154 | 0.0% | 52.00% | +132.2% |
| Q3 2022 | $48,462,000 | +19.1% | 3,846,154 | 0.0% | 22.39% | +39.3% |
| Q2 2022 | $40,692,000 | -34.9% | 3,846,154 | 0.0% | 16.07% | -36.8% |
| Q1 2022 | $62,538,000 | +45.4% | 3,846,154 | 0.0% | 25.44% | +41.3% |
| Q4 2021 | $43,000,000 | – | 3,846,154 | – | 18.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $62,538,000 | 25.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,733 | $27,979,000 | 5.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 57,000 | $19,282,000 | 4.35% |
| MPM BioImpact LLC | 639,089 | $10,392,000 | 2.79% |
| Parkman Healthcare Partners LLC | 476,978 | $7,756,000 | 2.27% |
| Sarissa Capital Management LP | 1,390,790 | $22,614,000 | 2.14% |
| Ghost Tree Capital, LLC | 350,000 | $5,691,000 | 1.24% |
| Lisanti Capital Growth, LLC | 662,644 | $10,775,000 | 1.21% |
| Baker Brothers Advisors | 12,710,818 | $206,678,000 | 1.19% |
| Tamarack Advisers, LP | 125,000 | $2,033,000 | 0.96% |